AR
ARKG.LSE ARK Genomic Revolution UCITS ETF Class A USD Accumulation
- USD
No recent price
- Total assets
- 8.76M
- Expense ratio
- 0.78%
- Dividend yield
- -
- 1-year return
- +63.43%
- Holdings
- 33
- Since
- 2024
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does ARKG.LSE invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (95.5%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (95.5%)
- Top 3 holdings: 23.9% of the fund
Asset allocation
- US stocks 95.5%
- Non-US stocks 7.7%
Top holdings
- Tempus AI, Inc. Class A Common Stock 8.97%
- Twist Bioscience Corp 8.23%
- 10X Genomics Inc 6.66%
- Natera Inc 5.37%
- Crispr Therapeutics AG 5.17%
ARK Genomic Revolution UCITS ETF Class A USD Accumulation performance
Sharpe ratio 0.00- This year
- +73.79%
- 1 year
- +63.43%
- 3 years
- 0.00%
- 5 years
- 0.00%
Volatility 41.9% over 1 year. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
ARKG.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
ARK Genomic Revolution UCITS ETF Class A USD Accumulation top holdings
57.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Tempus AI, Inc. Class A Common Stock TEM.US | Healthcare | United States | 8.97% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 8.23% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 6.66% |
| Natera Inc NTRA.US | Healthcare | United States | 5.37% |
| Crispr Therapeutics AG CRSP.US | Healthcare | United States | 5.17% |
| Eli Lilly and Company LLY.US | Healthcare | United States | 5.07% |
| CareDx Inc CDNA.US | Healthcare | United States | 5.01% |
| Absci Corp ABSI.US | Healthcare | United States | 4.84% |
| Illumina Inc ILMN.US | Healthcare | United States | 4.48% |
| Veracyte Inc VCYT.US | Healthcare | United States | 3.97% |
The 10 largest of 33 holdings.
ARKG.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
ARKG.LSE regional exposure
- North America95.5%
- Europe Developed5.2%
- United Kingdom2.9%
Share of the stocks in the fund.
Company size
Average market cap 6.77B- Mega cap5.1%
- Medium cap17.6%
- Small cap28.6%
- Micro cap43.9%
ARK Genomic Revolution UCITS ETF Class A USD Accumulation fund profile
- Fund name
- ARK Genomic Revolution UCITS ETF Class A USD Accumulation
- Ticker
- ARKG.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Apr 12, 2024
- Trading currency
- USD
- Expense ratio
- 0.78%